United Therapeutics buy UBS Group AG
Start price
30.06.25
/
50%
€244.10
Target price
30.06.26
€328.48
Performance (%)
0.00%
Price
30.06.25
€244.10
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG is currently unchanged from the start price. This prediction currently runs until 30.06.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| United Therapeutics | 0.00% |
| iShares Core DAX® | 2.339% |
| iShares Nasdaq 100 | 2.017% |
| iShares Nikkei 225® | 4.496% |
| iShares S&P 500 | 1.174% |
Comments by UBS_Group_AG for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Corporation (NASDAQ: UTHR) had its price target lowered by analysts at UBS Group AG from $410.00 to $385.00. They now have a "buy" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by UBS_Group_AG for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€355.30
08.01.25
08.01.25
€460.94
08.01.26
08.01.26
-31.30%
30.06.25
30.06.25
United Therapeutics
Start price
Target price
Perf. (%)
€292.80
08.07.24
08.07.24
€341.51
08.07.25
08.07.25
-16.63%
30.06.25
30.06.25